Showing results (201-210 of 1,342) with videos related to
Sort By:
Pageof 135
Revue Medicale De Liege|June 14, 2014
[Bydureon: first once weekly GLP-1 receptor agonist (exenatide LAR)]A J ScheenRevue Medicale De Liege|February 10, 2000
[How I assess ... home glycemic control in diabetic patients]A J ScheenRevue Medicale De Liege|April 16, 2003
[Clinical trial of the month. The STENO-2 study: a plea for global and intensive management of the type 2 diabetic patient]A J Scheen, F EstrellaRevue Medicale De Liege|January 14, 2022
[SGLT2 inhibitors and RAAS blockers : similarities, differences and complementarity]A J Scheen, P DelanayeRevue Medicale De Liege|June 7, 2011
[Medication of the month. Femoston Low (0.5 mg estradiol plus 2.5 mg dydrogesterone) for menopausal hormonal replacement therapy]A J Scheen, U GaspardRevue Medicale De Liege|January 12, 2023
[EMPA-KIDNEY: empagliflozin in chronic kidney disease]P Delanaye, A J ScheenRevue Medicale De Liege|May 8, 2009
[Vildagliptin (Galvus) and fixed combination vildagliptine-metformin (Eucreas) in the treatment of type 2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|April 9, 2020
[Extended indications for antidiabetic agents with cardio-renal protection in updated international recommendations for themanagement of at risk patients with type2 diabetes]A J Scheen, N PaquotRevue Medicale De Liege|August 15, 2000
[Recommendations for the treatment of obesity]F Luyckx, A J ScheenPageof 135